Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Patent    exchanges : Amex    save search

Can-Fite Broadens its Strong Intellectual Property (IP) for NASH: Received Patent Allowance in Canada
Published: 2024-02-28 (Crawled : 12:30) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K twitter stocktwits trandingview |
Health Technology
| | O: -1.9% H: 4.37% C: 0.98%

patent canada
Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company’s Portfolio
Published: 2024-01-30 (Crawled : 13:00) - globenewswire.com
ANVS | $10.09 2.44% -0.15% 220K twitter stocktwits trandingview |
Health Technology
| | O: 5.45% H: 0.0% C: -10.42%

patent treatment application
DAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMES
Published: 2024-01-09 (Crawled : 13:00) - globenewswire.com
DXR | $9.74 0.73% 8.3K twitter stocktwits trandingview |
Health Technology
| | O: -0.98% H: 0.75% C: -0.1%

patent treatment blood smart technology
Lineage Announces Issuance of U.S. Patent Covering Proprietary Manufacturing and Differentiation Process for Retinal Pigmented Epithelial Cells
Published: 2023-10-11 (Crawled : 13:00) - biospace.com/
LCTX | $1.15 -4.17% 0.0% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -1.49% H: 0.76% C: -3.03%

patent
Kelso Technologies Inc. Key Patent Application Filed for Automated Traction Optimization Method for Vehicle Suspension Systems
Published: 2023-09-12 (Crawled : 13:30) - globenewswire.com
KIQ | $0.1349 0.0% 12K twitter stocktwits trandingview |
Producer Manufacturing
| | O: 0.47% H: 0.0% C: -6.38%

patent application
CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product Defencath
Published: 2023-08-30 (Crawled : 12:00) - globenewswire.com
CRMD | News | $5.27 -2.77% -2.85% 2M twitter stocktwits trandingview |
Health Technology
| | O: 0.24% H: 0.49% C: -0.97%

patent
Annovis Bio Announces the Filing of a Groundbreaking Patent
Published: 2023-06-27 (Crawled : 13:00) - biospace.com/
ANVS | $10.09 2.44% -0.15% 220K twitter stocktwits trandingview |
Health Technology
| | O: 3.13% H: 0.34% C: -1.66%

patent
CorMedix Inc. Announces Notice of Allowance for U.S. Patent Application Covering Lead Product DefenCath
Published: 2023-05-01 (Crawled : 13:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320 twitter stocktwits trandingview |
Communications
| | O: 0.36% H: 0.0% C: 0.0%
CRMD | News | $5.27 -2.77% -2.85% 2M twitter stocktwits trandingview |
Health Technology
| | O: 0.4% H: 3.43% C: 3.23%

patent application
Annovis Bio Announces Issuance of U.S. Patent Covering the Use of Lead Drug Candidate, Buntanetap, for Prevention or Treatment of Disease States Due to Metal Dis-Homeostasis in Healthy or Sick Humans
Published: 2023-04-27 (Crawled : 11:00) - globenewswire.com
ANVS | $10.09 2.44% -0.15% 220K twitter stocktwits trandingview |
Health Technology
| | O: 2.36% H: 1.52% C: -1.18%

drug patent disease treatment
Palatin Issued Patent on Vyleesi® (Bremelanotide Injection) For Hypoactive Sexual Desire Disorder in Patients With Controlled Hypertension
Published: 2023-02-28 (Crawled : 13:00) - palatin.com
PTN | $1.84 -2.65% 0.05% 150K twitter stocktwits trandingview |
Health Technology
| | O: 9.16% H: 9.59% C: 8.56%

vyleesi patent hypertension
Annovis Bio Announces Filing of Patent Covering the Administration of Buntanetap and Its Analogues for the Treatment of Mental Illnesses
Published: 2023-02-01 (Crawled : 13:00) - prnewswire.com
ANVS | $10.09 2.44% -0.15% 220K twitter stocktwits trandingview |
Health Technology
| | O: 4.3% H: 7.43% C: 4.76%

treatment patent buntanetap
Can-Fite: Namodenoson Significantly Inhibits Pancreatic Cancer in Preclinical Studies—A Patent Has Been Filed
Published: 2023-01-24 (Crawled : 13:00) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K twitter stocktwits trandingview |
Health Technology
| | O: 1.98% H: 3.87% C: -8.14%

namodenoson patent preclinical cancer pancreatic
Navidea Biopharmaceuticals Announces the Notice of Allowance for U.S. Patent Application for Key Component of the Company’s Cancer Immunotherapy Pipeline
Published: 2023-01-03 (Crawled : 14:00) - biospace.com/
NAVB | $0.035 50.69% 15K twitter stocktwits trandingview |
Health Technology
| | O: 10.0% H: 29.09% C: 16.88%

patent immunotherapy application cancer
Xenetic Biosciences, Inc. Announces Signing of Patent Assignment Related to Collaboration With VolitionRx Limited and CLS Therapeutics
Published: 2022-10-11 (Crawled : 13:00) - biospace.com/
XBIO | $4.14 7.32% 770 twitter stocktwits trandingview |
Health Technology
| | O: 5.26% H: 0.0% C: -4.15%
VNRX | $0.616 -0.19% 0.0% 250K twitter stocktwits trandingview |
Health Technology
| | O: -0.63% H: 0.0% C: -5.03%

patent collaboration therapeutics
Annovis Bio Submits an International Patent Application to Cover the Treatment of Neurological Injuries Caused by Infections
Published: 2022-06-09 (Crawled : 14:00) - biospace.com/
ANVS | $10.09 2.44% -0.15% 220K twitter stocktwits trandingview |
Health Technology
| | O: 0.8% H: 0.0% C: -14.19%

treatment patent neurological application infections international
IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders
Published: 2022-06-09 (Crawled : 07:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K twitter stocktwits trandingview |
Health Technology
| | O: 48.37% H: 14.13% C: -1.3%

patent
Can-Fite Granted Key NASH Patent in Israel
Published: 2022-05-16 (Crawled : 12:20) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K twitter stocktwits trandingview |
Health Technology
| | O: 4.79% H: 0.0% C: -4.44%

patent israel granted nash grant
Navidea Biopharmaceuticals Announces the Notice of Allowance for U.S. Patent Application for Diagnosis and Treatment of Leishmaniasis
Published: 2022-04-19 (Crawled : 12:00) - biospace.com/
NAVB | $0.035 50.69% 15K twitter stocktwits trandingview |
Health Technology
| | O: 20.93% H: 0.0% C: 0.0%

treatment patent application diagnostic
Can-Fite: Namodenoson’s Treatment of Liver Fibrosis Receives Notice of Allowance from U.S. Patent Office
Published: 2022-03-14 (Crawled : 12:30) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K twitter stocktwits trandingview |
Health Technology
| | O: 6.19% H: 4.85% C: -8.49%

treatment fibrosis patent liver namodenoson
Myomo Strengthens Intellectual Property Portfolio with Receipt of Key Patent in Japan
Published: 2022-02-17 (Crawled : 22:00) - myomo.com
MYO 4 | $3.19 13.12% -2.19% 320K twitter stocktwits trandingview |
Distribution Services
| | O: 0.66% H: 1.55% C: -2.37%

patent intel
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.